Madhav Dhodapkar, MBBS, Emory University School of Medicine, Atlanta, GA, provides an overview of the Phase II LINKER-MM1 trial ...

YouTube-VJHemOnc – Video Journal of Hematology & HemOnc

... linvoseltamab, a CD3-directed B-cell maturation antigen (BCMA) ... linvoseltamab, which reduces the frequency of administration to improve ...

YouTube-Oncology Data Advisor

Improving Lives | Finding the Cure Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization ...

YouTube-International Myeloma Foundation

... linvoseltamab. The study also showed that patients with very high baseline sBCMA demonstrated high overall response rates (ORR) to linvoseltamab ...

VJHemOnc-VJHemOnc – Video Journal of Hematology & HemOnc

Interview with Hans Lee, MD from the Anderson Cancer Center at ASCO 2023. Filmed June 3rd, 2023. The HealthTree Foundation for Multiple ...

YouTube-HealthTree Foundation for Multiple Myeloma

LINKER-MM1 study presented the efficacy and safety of linvoseltamab, a BCMA bi-specific antibody, in patients with relapsed or refractory ...

YouTube-International Myeloma Foundation

Shonali Midha, MD, discusses opportunities for utilizing bispecific antibodies in treating relapsed/refractory multiple myeloma.

YouTube-Dana-Farber Cancer Institute

Mary DeRome, Senior Director of Medical Communications and Education at the Multiple Myeloma Research Foundation, gets answers to frequently ...

YouTube-Multiple Myeloma Research Foundation - MMRF

Interview with Carolina Schinke, MD from University of Arkansas for Medical Sciences at ASH 2023. Filmed December 9, 2023.

YouTube-HealthTree Foundation for Multiple Myeloma